What does CUSIP 022101510 represent in this 13F holders report?

CUSIP 022101510 is the security identifier for 022101510 - CORVUS PHARMACEUTICALS INC - COM used to aggregate holder disclosures.

How many institutions held 022101510 - CORVUS PHARMACEUTICALS INC - COM in Q4 2025?

No institutional holders were reported for 022101510 - CORVUS PHARMACEUTICALS INC - COM in Q4 2025; review adjacent reporting periods for trend context.

CORVUS PHARMACEUTICALS INC - COM

CUSIP: 022101510

Q4 2025 13F Holders as of 31 Dec 2025

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -768,500
Total reported value: $0
Number of holders: 0
Value change: -$5,663,845
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 022101510?
CUSIP 022101510 identifies 022101510 - CORVUS PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Previous quarter: Q3 2025

Recent filing periods for CUSIP 022101510:

Q4 2025 Q3 2025 Q1 2025 Q4 2024

CORVUS PHARMACEUTICALS INC - COM

Q4 2025 13F Holders as of 31 Dec 2025

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of CORVUS PHARMACEUTICALS INC - COM as of Q4 2025.